Literature DB >> 10748292

A FISH study of variant Philadelphia rearrangements.

K S Reddy1, V Sulcova.   

Abstract

A total of 39 variant Philadelphia (Ph) translocations were studied by fluorescence in situ hybridization (FISH) using MBCR/ABL, mBCR/ABL, or DBCR/ABL probes. Seven cases did not have a BCR/ABL fusion signal. Of a total of 32 fusion-positive cases, 5 were simple variants involving chromosome 22 and another chromosome apart from chromosome 9; 23 were complex variants involving chromosomes 22, 9, and a third chromosome (18 cases), or 22, 9, and two other chromosomes (4 cases). Masked Ph rearrangements were detected in 4 cases. One case was a Ph chromosome mimic. Fluorescence in situ hybridization has become a widely used method for studying Ph rearrangements. The latest probe that is being used is the DBCR/ABL (double reciprocal BCR/ABL signals). The expected pattern for this probe is one green ABL signal (1G) on the normal 9, one red BCR signal (1R) on the normal 22, and two fusion signals, BCR/ABL and ABL/BCR (2F), on a derivative 22 and a derivative 9, respectively. Deviant patterns from 1G1R2F, and sometimes 1G1R2F, were indicative of a variant, as long as there was a fusion signal. However, in interphase analysis, it is not possible to visualize a variant rearrangement, and when a deviant pattern involving at least one fusion signal is observed, the following possibilities should be contemplated. The different patterns observed in fifteen Ph variants are described. The patterns observed in variants studied with the DBCR/ABL probe were 2G2R1F (40%), 1G1R2F (20%), 1G1R1F (20%), 1G2R1F (13.3%), and 2G1R1F (6.66%). A single mechanism is involved in the formation of each of these patterns. A 2G2R1F, FISH pattern in 6 cases appears to involve a single concerted event of simultaneous breaks on the participating chromosomes followed by mismatched joining. The three cases with 1G1R2F most probably arose by two sequential rearrangements. The 1G1R1F pattern suggests that either the BCR and ABL breakpoints are different, or there are deletions at the breakpoints, because residual signals are not observed. Two independent events appear to be involved in 1G2R1F with a reverse cryptic 9,22 rearrangement as the first event. In one case of 2G1R1F, the plausible explanation is an insertion of ABL next to BCR and either a simultaneous or a sequential translocation with another chromosome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748292     DOI: 10.1016/s0165-4608(99)00187-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  A rare case of three-way complex variant translocation in chronic myeloid leukemia t(6;9;22)(p21;q34;q11): A case report.

Authors:  Muhammad Asif; Abrar Hussain; Abdul Wali; Nazeer Ahmad; Naheed Sajjad; Muhammad Amir; Irfan Ali; Peter Natesan Pushparaj; Mahmood Rasool
Journal:  Biomed Rep       Date:  2017-08-17

2.  A rare case of a three way complex variant positive Philadelphia translocation involving chromosome (9;11;22)(q34;p15;q11) in chronic myeloid leukemia: A case report.

Authors:  Muhammad Asif; Abrar Hussain; Mahmood Rasool
Journal:  Oncol Lett       Date:  2016-07-07       Impact factor: 2.967

3.  Chronic myeloid leukemia with insertion-derived BCR-ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis.

Authors:  Zhenya Tang; Gokce A Toruner; Guilin Tang; C Cameron Yin; Wei Wang; Shimin Hu; Beenu Thakral; Sa A Wang; Roberto N Miranda; Joseph D Khoury; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

4.  Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients.

Authors:  Ayda Bennour; Ines Ouahchi; Yosra Ben Youssef; Monia Zaier; Mohamed Adnéne Laatiri; Imed Harrabi; Balkis Meddeb; Moez Elloumi; Abderrahim Khelif; Ali Saad; Halima Sennana
Journal:  Med Oncol       Date:  2011-04-03       Impact factor: 3.064

5.  Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population.

Authors:  Yanmin Zhao; Lizhen Liu; Yingjia Wang; Gongqiang Wu; Xiaoyu Lai; Weijie Cao; Yi Luo; Yamin Tan; Jimin Shi; Wanzhuo Xie; Xiujin Ye; Zhen Cai; Maofang Lin; He Huang
Journal:  Int J Hematol       Date:  2009-04-07       Impact factor: 2.490

6.  A Novel Four-Way Complex Variant Translocation Involving Chromosome 46,XY,t(4;9;19;22)(q25:q34;p13.3;q11.2) in a Chronic Myeloid Leukemia Patient.

Authors:  Muhammad Asif; Mohammad Sarwar Jamal; Abdul Rehman Khan; Muhammad Imran Naseer; Abrar Hussain; Hani Choudhry; Arif Malik; Shahida Aziz Khan; Maged Mostafa Mahmoud; Ashraf Ali; Saima Iram; Kashif Kamran; Asim Iqbal; Zainularifeen Abduljaleel; Peter Natesan Pushparaj; Mahmood Rasool
Journal:  Front Oncol       Date:  2016-05-30       Impact factor: 6.244

7.  A rare case of complex variant translocation of t(9;22;16)(q34;q11.2;q24) in a newly diagnosed patient with chronic myeloid leukemia.

Authors:  Bradley J Grant; Zhenya Tang; Gokce A Toruner; Ali Mahdi; Lindsay Bigham; Jianli Dong; Tejo Musunuru; Jayati Mallick; Kirill A Lyapichev
Journal:  Leuk Res Rep       Date:  2022-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.